SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77502.12
579.48 (0.75%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Windlas Biotech Ltd.	Q V PT	1,778 Small Cap	861.40 (-0.05%)	26.76	3.33	18.24	17.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Cipla Ltd.	Q V PT	1,17,642 Mid Cap	1,456.25 (-0.05%)	30.33	3.42	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Orchid Pharma Ltd.	Q V PT	4,958 Small Cap	977.50 (0.46%)	109.67	3.62	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Health X Platform Ltd.	Q V PT	989 Small Cap	311 (-1.91%)	N/A	3.65	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Gland Pharma Ltd.	Q V PT	40,341 Small Cap	2,445.50 (-0.72%)	31.04	3.73	9.35	7.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Syngene International Ltd.	Q V+ PT	17,755 Small Cap	439.85 (1.92%)	58.23	3.77	10.89	4.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	3B Blackbio Dx Ltd.	Q V PT	1,037 Small Cap	1,207.75 (0.84%)	21.02	3.8	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Aurobindo Pharma Ltd.	Q V+ PT	89,762 Mid Cap	1,560.05 (0.47%)	37.17	3.95	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Indegene Ltd.	Q V+ PT	12,397 Small Cap	514.60 (0.26%)	30.91	3.95	34.59	31.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Themis Medicare Ltd.	Q V PT	1,097 Small Cap	119.15 (7.73%)	N/A	4.09	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	10,027 Small Cap	637.05 (1.00%)	89.81	4.13	10.00	11.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	1,033 Small Cap	131 (-0.04%)	104.32	4.19	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Zydus Lifesciences Ltd.	Q V PT	1,09,691 Mid Cap	1,099.65 (-0.83%)	21.76	4.22	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Alivus Life Sciences Ltd.	Q V PT	14,232 Small Cap	1,159.50 (2.23%)	25.21	4.27	9.20	6.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Viyash Scientific Ltd.	Q V PT	12,772 Small Cap	292.35 (1.48%)	72.04	4.39	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Novartis India Ltd.	Q V+ PT	3,587 Small Cap	1,452.70 (0.39%)	38.49	4.39	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Cohance Lifesciences Ltd.	Q V+ PT	17,294 Small Cap	452.05 (0.17%)	96.49	4.42	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Shilpa Medicare Ltd.	Q V+ PT	11,752 Small Cap	600.85 (5.26%)	48.29	4.54	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Granules India Ltd.	Q V+ PT	20,482 Small Cap	826.55 (1.84%)	51.12	4.66	5.58	-0.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Alkem Laboratories Ltd.	Q V+ PT	65,712 Mid Cap	5,495.95 (-1.22%)	30.07	4.69	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Artemis Medicare Services Ltd.	Q V PT	4,103 Small Cap	259.15 (-1.24%)	39.66	4.72	10.15	32.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	GPT Healthcare Ltd.	Q V PT	1,284 Small Cap	156.45 (4.40%)	30.41	4.76	13.96	24.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Hester Biosciences Ltd.	Q V PT	1,853 Small Cap	2,178.65 (-0.67%)	35.57	4.81	6.98	0.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Indraprastha Medical Corporation Ltd.	Q V+ PT	3,571 Small Cap	389.55 (0.88%)	19.45	4.82	10.30	29.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Pfizer Ltd.	Q V PT	20,301 Small Cap	4,437.70 (-0.88%)	28.1	4.83	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	SMS Pharmaceuticals Ltd.	Q V+ PT	3,910 Small Cap	417.50 (1.93%)	44.63	4.86	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Bliss GVS Pharma Ltd.	Q V+ PT	5,584 Small Cap	526.50 (0.31%)	57.64	4.88	9.41	4.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Lupin Ltd.	Q V PT	1,09,676 Mid Cap	2,398.70 (0.09%)	20.57	4.89	8.11	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Advanced Enzyme Technologies Ltd.	Q V PT	3,512 Small Cap	313.60 (-0.35%)	26.64	4.95	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Kovai Medical Center & Hospital Ltd.	Q V+ PT	6,574 Small Cap	6,007.95 (-0.69%)	26.89	4.98	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	298.65	8.92%
Themis Medicare	119.15	7.73%
Dishman Carbogen Amc	188	7%
Shilpa Medicare	600.85	5.26%
GPT Healthcare	156.45	4.40%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
KMC Speciality Hosp.	133.60	-5.01%
Morepen Laboratories	59.71	-4.63%
Fischer Medical	39.08	-4.59%
Shree Ganesh Remed.	642.40	-4.38%
Gufic Biosciences	385.40	-2.24%

News about Top Pharma Companies in India

Jul, 2026

Alkem Laboratories informs about newspaper advertisement

Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI LODR Regulations, Alkem Laboratories has informed that it enclosed a copy of advertisement published in today's newspapers, Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 52nd Annual General Meeting of the Company to be held through video conferencing (VC)/ other audio visual means (OAVM). The same is also available on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Themis Medicare informs about disclosure

Themis Medicare has informed that the exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Lupin gets EIR from USFDA for Somerset facility

The inspection was conducted from April 13, 2026, to April 17, 2026

Jul, 2026

Windlas Biotech submits AGM notice

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III of the said Regulations, Windlas Biotech has informed that it enclosed a copy of the Notice of the 25th Annual General Meeting (AGM) of the Company scheduled to be held on Thursday, July 23, 2026 at 01.00 PM (IST) through Video Conferencing (VC)/Other Audio ,Visual Means (OAVM), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. ln compliance with the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of the Listing Regulations, the Company is pleased to provide to its Members, facility to exercise their right to vote at the 25th AGM scheduled to be held on July 23, 2026, by electronic means and the business mentioned in the AGM Notice may be transacted through e-voting services provided by MUFG Intime India at https://instavote.linkintime.co.in/. The Company has fixed July 16, 2026 as the ‘cut-off date’ for ascertaining the names of members, holding shares of the Company, who will be entitled to cast their votes electronically during July 20, 2026 (9:00 AM) to July 22, 2026 (5:00 PM) and also during AGM in respect of business to be transacted at the aforesaid AGM and for the purpose of receiving dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Shilpa Medicare informs about disclosure

Pursuant to Regulation 30 read with other applicable provisions of the SEBI Listing Regulations, Shilpa Medicare has informed that Shilpa Biologicals (SBPL), a wholly owned subsidiary of the Company, has entered into Co-development and supply agreement with Orion Corporation (‘Orion’) a globally recognized pharmaceutical company headquartered in Finland. Details with respect to the above-mentioned event as required under Regulation 30 of Schedule Ill of the SEBI Listing Regulations and SEBI Circular dated 30th January 2026 are provided in Annexure I to this letter. A press release to be issued in relation to the above matter is enclosed.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Aurobindo Pharma gains as its arm completes acquisition of Lannett Company

Lannett has become a wholly owned subsidiary of Aurobindo Pharma USA Inc

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	KMC Speciality Hospitals (India) Ltd.	2,179 Crore
2	Nectar Lifesciences Ltd.	230 Crore
3	Dishman Carbogen Amcis Ltd.	2,948 Crore
4	Unichem Laboratories Ltd.	3,263 Crore
5	Shalby Ltd.	1,873 Crore
6	Lincoln Pharmaceuticals Ltd.	1,253 Crore
7	Natco Pharma Ltd.	16,725 Crore
8	Fabtech Technologies Ltd.	719 Crore
9	Sigachi Industries Ltd.	879 Crore
10	Krsnaa Diagnostics Ltd.	1,857 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	25.35
Lupin Ltd. (M)	Somewhat Good	2,399	1,09,676	20.57	4.89	11.90	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,525	82,399	101
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	41.28
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	39.25
Aurobindo Pharma Ltd. (M)	Very Good	1,560	89,762	34.75
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	31.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	55.22	9.22	33.44	15.51
Mankind Pharma Ltd. (M)	Very Good	2,487	1,02,729	50.42	6.27	31.67	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,872	4,49,048	39.12	5.37	22.41	23.50
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,195	61,943	45.48	5.89	12.07	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Alkem Laboratories informs about newspaper advertisement

Themis Medicare informs about disclosure

Lupin gets EIR from USFDA for Somerset facility

Windlas Biotech submits AGM notice

Shilpa Medicare informs about disclosure

Aurobindo Pharma gains as its arm completes acquisition of Lannett Company

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.